GW117: A novel serotonin (5-HT2C) receptor antagonist and melatonin (MT1/MT2) receptor agonist with potential antidepressant-like activity in rodents

被引：10
|
作者：
Gao, Nana [1 ]
Zheng, Wei [2 ]
Murezati, Tiliwaerde [2 ]
Gu, Wei [3 ]
Li, Xiaorong [2 ]
Jin, Zengliang [2 ]
机构：
[1] Captial Med Univ, Beijing Shijitan Hosp, Dept Gastrointestinal Surg & Clin Nutr, Beijing, Peoples R China
[2] Capital Med Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100069, Peoples R China
[3] Beijing Guangwei Pharmaceut Technol Co Ltd, Beijing, Peoples R China
来源：
CNS NEUROSCIENCE & THERAPEUTICS | 2021年 / 27卷 / 06期
基金：
中国国家自然科学基金;
关键词：
5‐ HT2C receptor; antidepressant; GW117; melatonin receptor; REUPTAKE INHIBITORS; AGOMELATINE; NOREPINEPHRINE; DRUGS; MODEL; DEPRESSION; STRESS; RATS;
D O I：
10.1111/cns.13630
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Aims To evaluate the antidepressant-like effect of compound GW117 in rodents using in vitro binding and uptake assays as well in vivo behavioral tests. Methods We investigated the target profile of GW117 using [S-35]-GTP gamma S and [H-3]PIP binding. Using the forced swimming test and chronic unpredictable stress in rats, tail suspension test in mice and rats, and learned helplessness model in mice, we further revealed the antidepressant-like and anxiolytic-like effects of GW117. Results The current study suggests that GW117 displays serotonin 2C (5-HT2C) receptor antagonist and melatonin type 1 and 2 (MT1/MT2) receptor agonist properties, as well as evident antidepressant and anxiolytic effects. Conclusion These data suggest that GW117 is probably a potent antidepressant.
引用
收藏
页码：702 / 713
页数：12
相关论文
共 50 条
  • [1] Synthesis and pharmacological evaluation of dual ligands for melatonin (MT1/MT2) and serotonin 5-HT2C receptor subtypes (II)
    Ettaoussi, Mohamed
    Peres, Basile
    Errazani, Aicha
    Boutin, Jean A.
    Caignard, Daniel-Henri
    Delagrange, Philippe
    Melnyk, Patricia
    Berthelot, Pascal
    Yous, Said
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 90 : 822 - 833
  • [2] Synthesis and Pharmacological Evaluation of a series of the Agomelatine Analogues as Melatonin MT1/MT2 Agonist and 5-HT2C Antagonist
    Ettaoussi, Mohamed
    Sabaouni, Ahmed
    Peres, Basile
    Landagaray, Elodie
    Nosjean, Olivier
    Boutin, Jean A.
    Caignard, Daniel-Henri
    Delagrange, Philippe
    Berthelot, Pascal
    Yous, Said
    CHEMMEDCHEM, 2013, 8 (11) : 1830 - 1845
  • [3] Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder
    Olie, Jean Pierre
    Kasper, Siegfried
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (05): : 661 - 673
  • [4] Possibilities of preventive treatment of migraine with the MT1-and MT2 agonist and 5-HT2c receptor antagonist agomelatin (valdoxan)
    Tabeeva, G. R.
    Sergeev, A. V.
    Gromova, S. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (09) : 32 - 36
  • [5] Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents
    Rosenzweig-Lipson, Sharon
    Sabb, Annmarie
    Stack, Gary
    Mitchell, Paul
    Lucki, Irwin
    Malberg, Jessica E.
    Grauer, Steve
    Brennan, Julie
    Cryan, John F.
    Rizzo, Stacey J. Sukoff
    Dunlop, John
    Barrett, James E.
    Marquis, Karen L.
    PSYCHOPHARMACOLOGY, 2007, 192 (02) : 159 - 170
  • [6] Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents
    Sharon Rosenzweig-Lipson
    Annmarie Sabb
    Gary Stack
    Paul Mitchell
    Irwin Lucki
    Jessica E. Malberg
    Steve Grauer
    Julie Brennan
    John F. Cryan
    Stacey J. Sukoff Rizzo
    John Dunlop
    James E. Barrett
    Karen L. Marquis
    Psychopharmacology, 2007, 192 : 159 - 170
  • [7] Recent advances in the development of melatonin MT1 and MT2 receptor agonists
    Mor, Marco
    Rivara, Silvia
    Pala, Daniele
    Bedini, Annalida
    Spadoni, Gilberto
    Tarzia, Giorgio
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (08) : 1059 - 1077
  • [8] Agomelatine, a MT1/MT2 melatonergic receptor agonist with serotonin 5-HT2C receptor antagonistic properties, suppresses Prevotella intermedia lipopolysaccharide-induced production of proinflammatory mediators in murine macrophages
    Hyeon, Jin-Yi
    Choi, Eun-Young
    Choe, So-Hui
    Park, Hae Ryoun
    Choi, Jeom-Il
    Choi, In Soon
    Kim, Sung-Jo
    ARCHIVES OF ORAL BIOLOGY, 2017, 82 : 11 - 18
  • [9] The expression of MT1, and MT2 melatonin receptor mRNA in several rat tissues
    Sallinen, P
    Saarela, S
    Ilves, M
    Vakkuri, I
    Leppäluoto, J
    LIFE SCIENCES, 2005, 76 (10) : 1123 - 1134
  • [10] New Quinoxaline Derivatives as Potential MT1 and MT2 Receptor Ligands
    Ancizu, Saioa
    Castrillo, Nerea
    Perez-Silanes, Silvia
    Aldana, Ignacio
    Monge, Antonio
    Delagrange, Philippe
    Caignard, Daniel-Henry
    Galiano, Silvia
    MOLECULES, 2012, 17 (07) : 7737 - 7757
12345